English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduOnsiteGene Inc. launches XDive®, the first 5-minute real-time PCR instrument, achieving 40 thermal cycles with fluorescent imaging in 5 minutes. With FDA EUA for COVID-19, XDive offers efficiency, processing 16 samples and 64 targets per run. OnsiteGene seeks global distributors and collaborators.
Tag: POCT
LumiraDx to Present on Impact of its Next-Generation Microfluidic Technology at American Association for Clinical Chemistry (AACC) Annual Conference in Chicago
LumiraDx, a next-generation point of care diagnostics company will be hosting an industry workshop at this week’s American Association for Clinical Chemistry (AACC) Annual Conference in Chicago. The workshop, held on July 27th, will include data-backed insights on the impact of LumiraDx’s advanced microfluidic technology over lateral flow point-of-care antigen tests, and the role of these rapid immunoassays in response to the COVID-19 pandemic.
AACC Releases Guidance Document on Using Point-of-Care Tests to Improve Patient Care
AACC has issued a new guidance document detailing best practices that hospitals and other healthcare institutions should follow when running a point-of-care testing program. As point-of-care tests emerge for more and more conditions—including COVID-19—the guidance emphasizes that it is essential for laboratory professionals and clinicians to collaborate on point-of-care testing programs to ensure this testing benefits patients.
Briefing: Point-of-Care Testing—Bringing the Lab to the Patient
Point-of-care testing is transforming healthcare: this type of testing helps patients get diagnosed and treated faster, and also makes it easier for patients in remote areas to have access to medical testing. Join AACC and leading experts in laboratory medicine for a discussion about what lies ahead for point-of-care testing and what needs to happen so that all patients can benefit from quality testing of this kind.